Open Heart. 2016 Jan 04;3(1):e000313. doi: 10.1136/openhrt-2015-000313. eCollection 2016.
A time-series study of percutaneous closure of patent foramen ovale: premature adoption?.
Open heart
Kian Nian Lew, Gianni D Angelini, William Hollingworth
Affiliations
Affiliations
- Faculty of Medicine and Dentistry , University of Bristol , Bristol , UK.
- Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust , Bristol , UK.
- School of Social and Community Medicine, University of Bristol , Bristol , UK.
PMID: 26835140
PMCID: PMC4716454 DOI: 10.1136/openhrt-2015-000313
Abstract
OBJECTIVES: To evaluate the impact of National Institute for Health and Care Excellence (NICE) guidance in January 2005 and subsequent trial evidence on the adoption of percutaneous closure of patent foramen ovale (PCPFO).
METHODS: A retrospective time series study was conducted using the Inpatient Hospital Episode Statistics (HES) England. A total of 3801 patients, aged ≥18 and ≤60 years, who had PCPFO from 1 April 2006 to 31 March 2012 in England. Percentage change annualised (PCA) in PCPFO procedure rates between initial NICE guidance and publication of trial results was analysed.
RESULTS: Between Quarter 2, 2006 and Quarter 4, 2009, 2163 PCPFO procedures were performed, with an increasing PCA of 48.4%. The procedure rate peaked before the presentation of equivocal results from the first randomised controlled trial (RCT) in late 2010, and declined between Quarter 4, 2009 and Quarter 4, 2011 (PCA=-15.3%). Of more than 2300 patients recruited to three RCTs, only 71 were recruited in English hospitals.
CONCLUSIONS: PCPFO was rapidly adopted after the publication of initial NICE guidance despite the absence of RCT evidence of efficacy. Very few English patients participated in international RCTs of PCPFO, suggesting that NICE recommendations also failed to encourage the generation of RCT evidence.
Keywords: CONGENITAL HEART DISEASE
References
- Circulation. 2009 May 26;119(20):2743-7 - PubMed
- Am J Cardiol. 2015 Mar 15;115(6):837-43 - PubMed
- Circ Cardiovasc Qual Outcomes. 2012 May;5(3):414-5 - PubMed
- Am J Med Sci. 2013 Sep;346(3):181-6 - PubMed
- N Engl J Med. 2014 Oct 2;371(14):1280-3 - PubMed
- Milbank Q. 2014 Mar;92(1):114-50 - PubMed
- Heart Lung Circ. 2009 Apr;18(2):140-2 - PubMed
- Lancet. 2009 Sep 26;374(9695):1089-96 - PubMed
- BMJ. 2003 Feb 15;326(7385):347-8 - PubMed
- Biometrics. 2006 Sep;62(3):847-54 - PubMed
- EuroIntervention. 2014 Mar 20;9(11):1342-9 - PubMed
- N Engl J Med. 2013 Mar 21;368(12):1092-100 - PubMed
- Neuroepidemiology. 2013;40(1):56-67 - PubMed
- J Clin Epidemiol. 1999 Dec;52(12):1143-56 - PubMed
- Heart. 2011 Mar;97(5):394-9 - PubMed
- Lancet Neurol. 2015 Sep;14(9):903-13 - PubMed
- N Engl J Med. 2012 Mar 15;366(11):991-9 - PubMed
- Int J Cardiol. 2013 Oct 9;168(4):4132-8 - PubMed
- Eur Heart J. 2013 Nov;34(43):3342-52 - PubMed
- Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1078-84 - PubMed
- BMJ. 2004 Apr 24;328(7446):969-70 - PubMed
- JAMA. 2001 Aug 15;286(7):821-30 - PubMed
- BMJ. 2012 Jul 31;345:e4710 - PubMed
- Heart Lung Circ. 2013 Nov;22(11):903-9 - PubMed
- Stat Med. 2000 Feb 15;19(3):335-51 - PubMed
- N Engl J Med. 1998 Jun 18;338(25):1838-9 - PubMed
- BMJ. 2013 Jun 18;346:f3011 - PubMed
- BMJ. 2013 May 07;346:f2771 - PubMed
- BMJ. 1998 Oct 31;317(7167):1185-90 - PubMed
- Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1123-38 - PubMed
- J Invasive Cardiol. 2012 Nov;24(11):608-11 - PubMed
- Ann Intern Med. 2013 Jan 1;158(1):55-9 - PubMed
- N Engl J Med. 2013 Mar 21;368(12):1083-91 - PubMed
- Catheter Cardiovasc Interv. 2013 Mar;81(4):660-5 - PubMed
- J Public Health (Oxf). 2012 Mar;34(1):138-48 - PubMed
- J Gen Intern Med. 2015 Feb;30(2):221-8 - PubMed
- Clin Res Cardiol. 2012 Oct;101(10):787-93 - PubMed
- Stroke. 2013 Sep;44(9):2640-3 - PubMed
- Catheter Cardiovasc Interv. 2015 May;85(6):1058-65 - PubMed
- Catheter Cardiovasc Interv. 2014 Feb 15;83(3):467-73 - PubMed
Publication Types
Grant support